Clomiphene-Metformin in Comparison with Letrozole-Metformin in Overweight Infertile Women with PCOS

Research Article | DOI: https://doi.org/10.31579/2578-8965/037

Clomiphene-Metformin in Comparison with Letrozole-Metformin in Overweight Infertile Women with PCOS

  • Ghoneim Bm 1
  • Farahat Ma 1
  • El-Badry Am, 1
  • El-Gharib Mn 1*

Professor of Obstetrics &Gynecology, Faculty of Medicine, Tanta University Tanta, Egypt

*Corresponding Author: Mohamed Nabih EL-Gharib, MB, BCH (Hon); DGO; DS; Professor of Obstetrics &Gynecology, Faculty of Medicine, Tanta University Tanta, Egypt E- Mail: mohamed.el-gharib@med.tanta.edu.eg

Citation: Ghoneim BM, Farahat MA, EL-Badry AM, and EL-Gharib MN. (2020) Clomiphene-Metformin in Comparison with Letrozole-Metformin in Overweight Infertile Women with PCOS. Obstetrics Genecology and Reproductive Sciences, 4(2): DOI: 10.31579/2578-8965/037

Copyright: © 2020. Mohamed Nabih EL-Gharib. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Received: 11 January 2020 | Accepted: 20 January 2020 | Published: 23 January 2020

Keywords: PCOS; clomiphene citrate; letrozole; pregnancy rate; infertility

Abstract

Background: polycystic ovarian syndrome (PCOS) is a common cause of infertility and is associated with chronic anovulation and hyperandrogenemia. Clomiphene citrate (CC) is still the first-line therapy for ovulation induction in these patients. Metformin, a biguanide, has been used to treat insulin resistance in women with PCOS. Furthermore, many reports confirmed that the addition of metformin to CC in the CC-resistant PCOS was highly effective in achieving ovulation. Letrozole, an aromatase inhibitor, has attracted attention for a long time to induce ovulation.

Aim of the work: In the current study, we aimed to compare the effect of administration of combined metformin–Clomiphene Citrate to that of combined metformin–letrozole in the induction of ovulation in infertile overweight women with PCOS. 40 infertile overweight cases with PCO were included.

Methods: Sixty participants had received metformin in aggregate with both CC (100 mg) or and similar number received letrozole (5 mg) plus metformin for 5 days starting from 3rd day of their menstrual cycle.

Results: The cumulative pregnancy rate CC-metformin was 21.66% and letrozole-metformin was 25%, the difference is insignificant.

Conclusion: CC and letrozole are similarly viable in the treatment of overweight women with PCOS, when joined with metformin treatment.

Introduction

Clomiphene citrate (CC) has been the mainline remedy to strengthen different follicular progression and ovulation. [1] CC by going about as antiestrogen on the central fearful framework, assembles the beat repeat of FSH and LH and gives a moderate gonadotropin lift to the ovary, and thusly over-coming ovulatory disrupting impacts. In spite of the way that CC is definitely not hard to use and achieves ovulation in numerous patients (57–91%), the pregnancy rates are disappointing (27–40%). It is an immediate aftereffect of the hostile effects of CC generally on the nature of the cervical organic liquid and the endometrial improvement during the prompting.  [2]

Letrozole inhibits the aromatase from making estrogens. Their instrument is release of the hypothalamic-pituitary center from estrogenic negative contribution, thusly growing gonadotropin release and occurring in affectation of ovarian follicles. [3] What's locally affects ovary and by androgen collection in-wrinkles follicle affectability to FSH.  [4]
Aromatase changes over androstenedione to estrone and testosterone to estradiol. Its activity can be outlined in a couple of tissues, tallying the ovaries, cerebrum, placenta, fat tissue, muscle, liver, bosoms and estrogen subordinate bosom malignant growth. Aromatase is conveyed in a tissue specific way. This synthetic is essentially imparted inside the ovaries of premenopausal women. AIs foresee the aromatase from making estrogens by focused reversible authority to the heme of its cytochrome P450 unit. [5] Letrozole has been demonstrated to be viable, in initiating ovulation and pregnancy in ladies with anovulatory PCOS and deficient CC reaction [6] and improving ovarian reaction to FSH in poor responders. [7] Letrozole has less symptoms than CC and gonadatropins, for example, various pregnancies and OHSS. [8]

Metformin is the most prepared and one of the premier convincing verbal prescriptions for type 2 diabetes. From the start, metformin was supported for patients with blocked glucose opposition at the recently settled tendency time frame; regardless more starting late its use was stretched out to various of the PCOS patients and for the total length of pregnancy. [9]
It diminishes hepatic gluconeogenesis and attack discharge, weight get and doesn't increase the opportunity for hypoglycemia. For PCOS patients and patients with type-II diabetes. Metformin is routinely given as a solitary expert to incite ovulation or as an assistant to readiness treatment some time as of late origination just as during the total course pregnancy. For patients with gestational diabetes mellitus metformin was given off an impression of being as viable and as secure as insult in the pregnancy.  [10]
This study aims to compare the effect of administration of combined metformin–Clomiphene Citrate to that of combined metformin–letrozole in induction of ovulation in infertile overweight women with PCOS.

Patients and Methods

This prospective randomized study was conducted at the department of Obstetrics & Gynecology in Tanta University and Al-Santa Central Hospitals during one year starting on March 2017.
Subjects:
The study included a total of 120 overweight women complaining of polycystic ovary syndrome and attending infertility outpatient clinic of Tanta University Hospital, from January 2017 to December 2019 for the treatment of infertility. All women included in the study gave written informed consent after proper counseling.
Inclusion criteria:
All patients fulfilled the following inclusion criteria:

Age 18-30 years.

Polycystic ovarian syndrome women according to Rotterdam Criteria 2003.(11)

Exclusion criteria:

  1.  Patients with a history of cardiovascular disease, diabetes or liver, and kidney failure were excluded.
  2. Similarly, patients whose partner's sperm count was less than 20 million/ ml and sperm motility less than 20% were also not included in the study.
  3. Patients who had undergone surgical treatment of infertility.
  4. Recent history of ovulatory inducing drugs within the last 3 months.

The patients were divided randomly into two groups through a series of blind envelopes numbered from 1 to 120. Each patient was invited to pull out an envelope and was placed in either:

Group A:Metformin–Clomiphene citrate group (envelopes number 1– 60).

Group B:Metformin– Letrozole group (envelopes number 61–120).

Methods

Informed written consents were obtained from the patients participating in this study after informing them about aims of study, the steps of study, drugs given and the capability to withdraw at any time.
I.Patient preparation: History taking including, clinical examination, transvaginal ultrasound examination, estimation of serum progesterone on days 21–23 of the cycle.
II.Induction of ovulation:
All patients of both groups were received 1500 mg metformin HCl daily, 500 mg three times a day (Cidophage; Chemical Industries Development, Cairo, Egypt). Also, the patients of the metformin– clomiphene citrate group (CC Group) received 100 mg clomiphene citrate (Clomid; Global Napi Pharmaceuticals, Cairo, Egypt) for 5 days starting from 3rd day of their menstrual cycle, and those in the metformin–letrozole group (letrozole Group) received 5 mg letrozole (Letrozole, Technopharma, Cairo, Egypt) for 5 days from 3rd day of their menstrual cycle. The condition of the ovaries was determined by transvaginal sonography every other day from the 10th of the cycle.

The hCG (a total of 10,000 IU IM, Choriamon; IBSA, Lugano, Switzerland) was given when one follicle measuring at least 18 mm was found. Patients were advised to have intercourse every other day for one week, starting 24–36 h after receiving HCG. The patients continued treatment for three successive cycles using the same protocol.
III.Follow up:
Follicle monitoring, and endometrial thickness measurement were done with the help of transvaginal sonography serially starting from the 6th day of the drug administration when at least one follicle reached maturity (>18mm). Confirmation of the pregnancy was done through urine test using a pregnancy test kit as well as through transvaginal sonography. After confirmation of pregnancy, these patients were followed up & treated as antenatal cases. Metformin was continued until 28 weeks. The two groups were compared to each other as regards:  The occurrence of ovulation which was be evaluated by folliculometry and progesterone level.
Statistical methods: The data were transferred to IBM cards using an IBM personal computer and analyzed with the Statistical Program for Social Sciences V11.0 (SPSS Inc, Chicago, IL) Descriptive statistics comprised the mean and standard deviation (SD). Analytical statistics comprised the student’s t-test to make comparisons between
Independent quantitative means, and the chi-square test (       ) to make comparisons between the different groups with regard to qualitative data. The chosen level of significance was p<0.05 in all studies. The p- value less than 0.05 were considered to be significant and the confidence interval for odds ratio was set at 95%.

Results

This prospective randomized study was conducted on 120 infertile overweight cases with PCOS in the department of Obstetrics & Gynecology in Tanta University and Al-Santa Central Hospital.

In the current study, there was no statistically significant difference between both groups as regards age or duration of infertility (mean age was 26.40 ± 5.20 years and mean duration of infertility was 2.90 ± 1.40 years in CC group and mean age was 26.50 ± 5.10years and mean duration of infertility was 2.88 ± 1.21 years in letrozole group. As regard BMI mean BMI was 27.50 ± 1.43 in CC group and mean BMI was 27.45

± 1.36 in letrozole group. As regard No. of cycles was 59cycles in CC group and 57cycles in letrozole group as depicted in table (1).

   Table (1): Comparison between the two studied groups according to the characteristics of the study population

P: p value for comparing between the two studied groups

*: Statistically significant at p ≤ 0.05

As regards to effect of treatment on ovulation: CC group reported 33cases (55.0%) ovulation at the first cycle after treatment, increased to 42 cases (70.0%) at the second cycle and to 54 cases (90.0%) at the third cycle. On the other hand, Letrozole group reported 36 cases (60.0%) ovulation at first cycle after treatment, which increased to 48 cases (80.0%) at the second cycle and 51 cases (85.0%) at the end of the third cycle. Correspondingly, CC group achieved a cumulative ovulation rate of 74.1 % while Letrozole group achieved 77.6%. In conclusion both drugs affected ovulation nearly to the same extent as shown in table (2).

 Table (2): Effect of treatment on ovulation in the studied groups

P: p value for comparing between the two studied groups

*: Statistically significant at p ≤ 0.05

Concerning the mean number of follicles, there is no statistically significant difference in number of follicles in the ovaries of both groups after treatment. In CC group, the mean variety of vesicle was 1.24 ±

0.48 at the first cycle, elevated to be 1.31 ± 0.71 at the second cycle, and to 1.42 ± 0.64 at the third cycle. Whereas  in  letrozole  group,  mean number of follicles  was 1.33  ±  0.52  at the  first cycle,  elevated to 1.37 ± 0.75 at the second cycle and 1.40±0.70 at the third cycle. There was no statistical difference between the two studied groups as represented in table (3).

Table (3): Effect of treatment on the number of follicles in studied groups

P: p value for comparing between the two studied groups

*: Statistically significant at p ≤ 0.05

In connection with the mean follicular diameter across, there is no factually huge distinction in mean follicular width (MFD) in the two groups. In CC group, it was 18.38 ± 2.03 mm, 17.49 ± 2.45 mm and

19.12 ± 3.21 mm at the first, second and third cycles respectively, while in Letrozole group, the corresponding values was 17.96 ± 1.97 mm, 17.62±2.18 mm and 18.93±3.06 mm at first, second and third cycles respectively. There was insignificant difference between both groups as displayed in table (4).

Table (4): Impact of treatment on the mean follicular width (MFD) in studied groups

P: p value for comparing between the two studied groups

*: Statistically significant at p ≤ 0.05

Regarding the number of follicles >18mm in both groups, there was no statistically significant difference between studied groups. In CC group the average number of follicles measuring >18 mm was 1.02±0.48, 0.95±0.49, and 1.24±0.43 at the first, second, and third

Cycles respectively, while in letrozole group, the analogous values were 1.11±0.50, 1.03±0.54, and 1.16±0.53 as shown in table (5).

 Table (5): Effect of treatment on the number of follicles >18mm

P: p value for comparing between the two studied groups

*: Statistically significant at p ≤ 0.05

There was insignificant difference between both groups.

Table (6) illustrates that there was no statistically significant difference was found between CC and letrozole groups as regards the cumulative number of follicles and cumulative number of mean follicular diameter. On the contrary, there was significant increase in Letrozole group than CC group as regard Cumulative Endometrial thickness as displayed in table (6).

Table (6):

 Effect of treatment on cumulative number of follicles, mean follicular diameter, and endometrial thickness between the study groups

P: p value for comparing between the two studied groups

*: Statistically significant at p ≤ 0.05

 The endometrium was thicker in the group accepting letrozole than in that getting clomiphene citrate (Table 7)

Table (7): Comparison between the two studied groups according to Endometrial Thickness on day of HCG administration in the three months separately and Cumulative Endometrial thickness.

P: p value for comparing between the two studied groups

*: Statistically significant at p ≤ 0.05

On the day of human chorionic gonadotrophin administration. In CC group the endometrial thickness was 5.84±0.59, 7.04±0.79, and 7.16±1.01 at the first, second and third cycles respectively, while in letrozole group, it was 7.91±0.71, 8.94±0.69, 10.11±0.93 at the first, second and third cycles respectively. The difference between both groups was statistically insignificant.

In connection with progesterone level at mid luteal phase, we found statistically significant increase in progesterone level in Letrozole group than CC group. In letrozole group progesterone values was 8.76±0.72, 8.95±0.51and 9.19±0.52 at the first, second and third cycles respectively, while in CC group, the equivalent values were 8.01±0.98, 8.29±0.87, 8.37±0.84 at first, second and third cycles respectively as revealed in the table (8).

 Table (8): Comparison between the Letrozole and CC groups according to progesterone (ng/ml) level in the three months

P: p value for comparing between the two studied groups

*: Statistically significant at p ≤ 0.05

The menses was regular in 65% of patients in CC group and in 55% of Letrozole group. Side effects as gastritis and sickness were happened in 5% of patients in both CC and letrozole groups.

Regarding pregnancy rate (per cycle) in CC and letrozole groups. There was no critical distinction (      = 186 & p = 0.666) between the pregnancy rates per cycles in CC and letrozole gatherings. The cumulative pregnancy rate in the CC group was 21.66% versus 25% for the letrozole group. In CC group, one case got pregnant in

The first month, six cases got pregnancy within the second and third months respectively. The corresponding figure relating to the letrozole group were three, six, and six cases got pregnancy within the first, second and third month respectively.

Discussion

PCOS is the most prevalent endocrine disorder in the reproductive age of women. In these patients, medications such as clomiphene citrate, letrozole and metformin are used to induce ovulation and overcome infertility [12].
Clomiphene citrate binds to estrogen receptors for prolonged periods i.e. weeks (2 weeks) rather than hours as with natural estrogen. This extended binding ultimately depletes estrogen receptors’ concentrations by interfering with the normal process estrogen receptors’ replenishment and may be responsible for the peripheral antiestrogenic effect of clomiphene citrate on the endometrium and cervix [13]

Letrozole is a nonsteroidal reversible, competitive aromatase inhibitor that is highly potent and selective. Letrozole has a half-life of about 45 hours [14].

The proposed mechanisms of ovarian stimulation by letrozole are a central effect on releasing the pituitary–hypothalamic axis from estrogen negative feedback and a local ovarian effect blocking androgen conversion to estrogen, with the concomitant accumulation of androgens inside the ovary, augmenting the follicular FSH receptor expression, and promoting folliculogenesis [15].

Metformin is an oral anti-diabetic drug from biguanides class used for the treatment of type II diabetes mellitus and acts as Insulin- sensitizing agents. Metformin is a safe and effective drug that is used for the treatment of PCOS patients. Metformin improves peripheral insulin sensitivity by reducing hepatic glucose production and increasing target tissue sensitivity to insulin. It also decreases androgens in both lean and obese women, leading to increased rates of spontaneous ovulation. Metformin may be used alone or in concert with other medications such as clomiphene citrate, it has been shown to increase the ovulatory response to clomiphene citrate in patients who were previously clomiphene-resistant [16].

The contemporary study was performed to compare the efficaciousness of combined metformin-clomiphene citrate thereto of metformin-letrozole in the induction of ovulation in infertile overweight ladies with PCOS.

In the present study, we found that the mean age was 26.40 ± 5.20 years for group A and 26.50 ± 5.10 years for group B. The BMI was 27.50 ± 1.43 for the group compared with 27.45 ± 1.36 for group B. The mean duration of infertility was 2.90 ± 1.40 years for group A and 2.88 ±1.21 years for group B. There was no statistically significant difference between the two groups as regards the clinical data.
These findings are in agreement with our result Sohrabvand et al., 2006 [17]; Bjelica et al., 2016 [18] and El Omda et al., 2018 [16].In the current study, we found that as regards ovulation rate in CC group showed ovulation rate was 55%, 70% and 90% of cases in first, second and third cycles respectively and letrozole group showed ovulation rate in 60%, 80% and 85% of cases in first, second and third
Cycles respectively, with no statistically significant difference between both groups.
The results are in agreement with Kar survey in which the ovulation rate was 73.08% in the letrozole group and 60.78% in the CC group, which was not statistically significant [19] .Moreover, this is in agreement with Badawy and associates found [20].
In the present investigation, we found that the total number of follicles mean follicular measurement and the number of follicles > 18 mm, had no factually critical contrast between CC and Letrozole groups at the first, second or third cycles. As the number of follicles in CC group was 1.24±0.48 at the first cycle, elevated to 1.31±0.71 at the second cycle and 1.42±0.64 at the third cycle and in letrozole group was 1.33±0.52 at the first cycle, elevated to 1.37±0.75 at the second cycle and 1.40±0.70 at the third cycle. The mean follicular diameter in CC group, was 18.38 ± 2.03 mm, 17.49 ± 2.45 mm and 19.12 ± 3.21 mm at the first, second or third cycles respectively, while in letrozole group, it was 17.96 ± 1.97 mm, 17.62±2.18 mm and 18.93±3.06 mm at first, second or third cycles. The number of follicles >18mm in CC group was 1.02±0.48, 0.95±0.49, and 1.24±0.43 at the 1st, 2nd and 3rd cycles respectively, while in letrozole group, it was 1.11±0.50, 1.03±0.54, 1.16±0.53 at first, second or third cycles.

In agreement with this result, El Omda and colleagues found that the mean number of follicles larger than 18mm in the CC group, was 1.25 ± 0.58 at the first cycle, elevated to be 1.32 ± 0.95 at the second cycle, and to 1.44 ± 0.70 at the third cycle. In the letrozole group, the mean number of follicles larger than 18mm was 1.36 ± 0.61 at the first cycle, elevated to 1.39 ± 0.99 at the second cycle and finally to 1.43±0.83 at the third cycles [16]. Also, our results are in harmony with Hu et al., study, in which the number and the size of mature follicles were similar between both groups. In the letrozole group, 86% of patients developed mature follicles, whereas 72% of patients in CC which was statistically insignificant [21]. Similarly, Bjelica and fellows studied 60 moderately obese women with PCOS, treated with either clomiphene citrate–metformin 31 patients or letrozole–metformin combinations 29 patients. They found that the number of follicles that > 18 mm did not show a statistically significant difference between the two groups, which is in agreement with our results [18].

Contrariwise, AlFozan and co-workers found that the total numbers of follicles during stimulation were similar between the Letrozole and CC groups (5.5 ± 0.4 in the letrozole group, 4.8 ± 0.3 in the CC group). The number of follicles>14 mm and >18 mm was significantly higher in the letrozole group [22].

In the existing study, there was an increment in the endometrial thickness in Letrozole than CC group (5.84 ± 0.59 versus 7.91 ± 0.71 mm) in the first month, (6.42± 0.89 versus 9.74±0.68) in the subsequent month and (7.16 ± 1.01versus 10.11 ± 0.93) in the third month (P- esteem 0.001). What's more, we found that the total endometrial thickness more great in the letrozole group than the CC group which was (6.48 ± 0.93) in the CC group and (9.25 ± 0.84) in letrozole group with measurably insignificant distinction.

On the contrary to the current outcomes, Bjelica and associates found that the endometrium was thicker in the group accepting letrozole than in that getting clomiphene citrate was 8.9 ± 1.7 mm, versus 6.3 ±1.3 mm, separately with a statistically significant difference. [18].

Samani et al. found an insignificant increase in endometrial thickness on the day of HCG administration in the letrozole group [23]. Likewise, Sohrabvand and co-workers [17]. looking at the adequacy of consolidated metformin–letrozole versus metformin–clomiphene citrate in 60 PCO infertile ladies arbitrarily partitioned into letrozole group (29 patients) and metformin–clomiphene group (30 patients) found that mean endometrial thickness upon the arrival of HCG administration was significantly less in subjects taking clomiphene citrate than the individuals who got letrozole (0.55 ± 0.28 versus 0.82 ± 0.13 cm). These results also, match those reported by Mitwally et al [7].

In concurrence with our outcomes, Kar (2012) found no measurably critical distinction between endometrial thicknesses (CC 7.61±1.96, letrozole 7.65 ± 2.10), on day of HCG administration [19]. Additionally, in the study performed by Al-Fozan and associates (2004), no significant difference in the endometrial thickness was found between Letrozole and CC groups (7.1 ± 0.2 mm in the letrozole gathering, 8.2 ±5.9 mm in the CC gathering) [22].

The investigation of Sammour and co-workers, found that patients getting the aromatase inhibitor had expanded endometrial thickness contrasted and those accepting CC (5.5 mm in letrozole versus 5.4 mm in CC) however, but the difference was statistically insignificant [24].

In the current investigation as respects progesterone level, there was a statistically significant increment in progesterone level in the group getting letrozole than in that accepting CC. In letrozole group, progesterone values were 8.76±0.52, 8.95±0.51and 9.19±0.52 at the first, second and third cycles respectively, while in CC group, the equivalent values were 8.01±0.98, 8.29±0.87, 8.37±0.84 at first, second and third cycles respectively with a statistically significant difference.

The previously mentioned outcome concerning progesterone disagrees with those of Abu Hashim and colleagues who found that progesterone increased significantly in patients getting clomiphene Citrate than in those accepting letrozole (11.4 ± 1.2 ng/ml versus 7.3 ±0.9 ng/ml respectively) [25]. On other hands the investigation of Elsedeek and Elmaghraby who found that mid-luteal progesterone was significantly lower in CC group [26].

In the ongoing study we insignificant increase in the pregnancy rate among letrozole than CC users. Pregnancy occurred in 13/60 in the CC group and 15/60 in the Letrozole group.

The results are in agreement with Hu and collaborators' study, who showed that the pregnancy rate in the letrozole group was higher than the CC group (20% versus 14%) but the difference was statistically not significant [22]. Likewise, Kar studied 103 infertile PCOS women treated either with 5mg letrozole or 100mg CC daily starting day 2 to day 6 of the menstrual cycle. There was no statistically significant difference between both groups as regard pregnancy rate which was 7.84% in the CC group & 21.56% in the letrozole group [19].

Furthermore, AbuHashim and associates found that pregnancy occurred in 14, 7% in the letrozole group and 14, 4% in CC-group with no statistically significant difference between both groups regarding the pregnancy rate [22].
Metformin caused symptoms as gastritis and nausea in 5% of our patients who received either CC or Letrozole. The frequency of an event of reactions in the present investigation was lower than that saw by Heard et al., 2002 [27].study on 48 anovulatory PCO patients which was 39%.

Conflicts of interest

The authors declare they have no conflicts of interest.

Running title

CC plus metformin versus letrozole plus metformin in treating PCO

References

Clearly Auctoresonline and particularly Psychology and Mental Health Care Journal is dedicated to improving health care services for individuals and populations. The editorial boards' ability to efficiently recognize and share the global importance of health literacy with a variety of stakeholders. Auctoresonline publishing platform can be used to facilitate of optimal client-based services and should be added to health care professionals' repertoire of evidence-based health care resources.

img

Virginia E. Koenig

Journal of Clinical Cardiology and Cardiovascular Intervention The submission and review process was adequate. However I think that the publication total value should have been enlightened in early fases. Thank you for all.

img

Delcio G Silva Junior

Journal of Women Health Care and Issues By the present mail, I want to say thank to you and tour colleagues for facilitating my published article. Specially thank you for the peer review process, support from the editorial office. I appreciate positively the quality of your journal.

img

Ziemlé Clément Méda

Journal of Clinical Research and Reports I would be very delighted to submit my testimonial regarding the reviewer board and the editorial office. The reviewer board were accurate and helpful regarding any modifications for my manuscript. And the editorial office were very helpful and supportive in contacting and monitoring with any update and offering help. It was my pleasure to contribute with your promising Journal and I am looking forward for more collaboration.

img

Mina Sherif Soliman Georgy

We would like to thank the Journal of Thoracic Disease and Cardiothoracic Surgery because of the services they provided us for our articles. The peer-review process was done in a very excellent time manner, and the opinions of the reviewers helped us to improve our manuscript further. The editorial office had an outstanding correspondence with us and guided us in many ways. During a hard time of the pandemic that is affecting every one of us tremendously, the editorial office helped us make everything easier for publishing scientific work. Hope for a more scientific relationship with your Journal.

img

Layla Shojaie

The peer-review process which consisted high quality queries on the paper. I did answer six reviewers’ questions and comments before the paper was accepted. The support from the editorial office is excellent.

img

Sing-yung Wu

Journal of Neuroscience and Neurological Surgery. I had the experience of publishing a research article recently. The whole process was simple from submission to publication. The reviewers made specific and valuable recommendations and corrections that improved the quality of my publication. I strongly recommend this Journal.

img

Orlando Villarreal

Dr. Katarzyna Byczkowska My testimonial covering: "The peer review process is quick and effective. The support from the editorial office is very professional and friendly. Quality of the Clinical Cardiology and Cardiovascular Interventions is scientific and publishes ground-breaking research on cardiology that is useful for other professionals in the field.

img

Katarzyna Byczkowska

Thank you most sincerely, with regard to the support you have given in relation to the reviewing process and the processing of my article entitled "Large Cell Neuroendocrine Carcinoma of The Prostate Gland: A Review and Update" for publication in your esteemed Journal, Journal of Cancer Research and Cellular Therapeutics". The editorial team has been very supportive.

img

Anthony Kodzo-Grey Venyo

Testimony of Journal of Clinical Otorhinolaryngology: work with your Reviews has been a educational and constructive experience. The editorial office were very helpful and supportive. It was a pleasure to contribute to your Journal.

img

Pedro Marques Gomes

Dr. Bernard Terkimbi Utoo, I am happy to publish my scientific work in Journal of Women Health Care and Issues (JWHCI). The manuscript submission was seamless and peer review process was top notch. I was amazed that 4 reviewers worked on the manuscript which made it a highly technical, standard and excellent quality paper. I appreciate the format and consideration for the APC as well as the speed of publication. It is my pleasure to continue with this scientific relationship with the esteem JWHCI.

img

Bernard Terkimbi Utoo

This is an acknowledgment for peer reviewers, editorial board of Journal of Clinical Research and Reports. They show a lot of consideration for us as publishers for our research article “Evaluation of the different factors associated with side effects of COVID-19 vaccination on medical students, Mutah university, Al-Karak, Jordan”, in a very professional and easy way. This journal is one of outstanding medical journal.

img

Prof Sherif W Mansour

Dear Hao Jiang, to Journal of Nutrition and Food Processing We greatly appreciate the efficient, professional and rapid processing of our paper by your team. If there is anything else we should do, please do not hesitate to let us know. On behalf of my co-authors, we would like to express our great appreciation to editor and reviewers.

img

Hao Jiang

As an author who has recently published in the journal "Brain and Neurological Disorders". I am delighted to provide a testimonial on the peer review process, editorial office support, and the overall quality of the journal. The peer review process at Brain and Neurological Disorders is rigorous and meticulous, ensuring that only high-quality, evidence-based research is published. The reviewers are experts in their fields, and their comments and suggestions were constructive and helped improve the quality of my manuscript. The review process was timely and efficient, with clear communication from the editorial office at each stage. The support from the editorial office was exceptional throughout the entire process. The editorial staff was responsive, professional, and always willing to help. They provided valuable guidance on formatting, structure, and ethical considerations, making the submission process seamless. Moreover, they kept me informed about the status of my manuscript and provided timely updates, which made the process less stressful. The journal Brain and Neurological Disorders is of the highest quality, with a strong focus on publishing cutting-edge research in the field of neurology. The articles published in this journal are well-researched, rigorously peer-reviewed, and written by experts in the field. The journal maintains high standards, ensuring that readers are provided with the most up-to-date and reliable information on brain and neurological disorders. In conclusion, I had a wonderful experience publishing in Brain and Neurological Disorders. The peer review process was thorough, the editorial office provided exceptional support, and the journal's quality is second to none. I would highly recommend this journal to any researcher working in the field of neurology and brain disorders.

img

Dr Shiming Tang

Dear Agrippa Hilda, Journal of Neuroscience and Neurological Surgery, Editorial Coordinator, I trust this message finds you well. I want to extend my appreciation for considering my article for publication in your esteemed journal. I am pleased to provide a testimonial regarding the peer review process and the support received from your editorial office. The peer review process for my paper was carried out in a highly professional and thorough manner. The feedback and comments provided by the authors were constructive and very useful in improving the quality of the manuscript. This rigorous assessment process undoubtedly contributes to the high standards maintained by your journal.

img

Raed Mualem

International Journal of Clinical Case Reports and Reviews. I strongly recommend to consider submitting your work to this high-quality journal. The support and availability of the Editorial staff is outstanding and the review process was both efficient and rigorous.

img

Andreas Filippaios

Thank you very much for publishing my Research Article titled “Comparing Treatment Outcome Of Allergic Rhinitis Patients After Using Fluticasone Nasal Spray And Nasal Douching" in the Journal of Clinical Otorhinolaryngology. As Medical Professionals we are immensely benefited from study of various informative Articles and Papers published in this high quality Journal. I look forward to enriching my knowledge by regular study of the Journal and contribute my future work in the field of ENT through the Journal for use by the medical fraternity. The support from the Editorial office was excellent and very prompt. I also welcome the comments received from the readers of my Research Article.

img

Dr Suramya Dhamija

Dear Erica Kelsey, Editorial Coordinator of Cancer Research and Cellular Therapeutics Our team is very satisfied with the processing of our paper by your journal. That was fast, efficient, rigorous, but without unnecessary complications. We appreciated the very short time between the submission of the paper and its publication on line on your site.

img

Bruno Chauffert

I am very glad to say that the peer review process is very successful and fast and support from the Editorial Office. Therefore, I would like to continue our scientific relationship for a long time. And I especially thank you for your kindly attention towards my article. Have a good day!

img

Baheci Selen

"We recently published an article entitled “Influence of beta-Cyclodextrins upon the Degradation of Carbofuran Derivatives under Alkaline Conditions" in the Journal of “Pesticides and Biofertilizers” to show that the cyclodextrins protect the carbamates increasing their half-life time in the presence of basic conditions This will be very helpful to understand carbofuran behaviour in the analytical, agro-environmental and food areas. We greatly appreciated the interaction with the editor and the editorial team; we were particularly well accompanied during the course of the revision process, since all various steps towards publication were short and without delay".

img

Jesus Simal-Gandara

I would like to express my gratitude towards you process of article review and submission. I found this to be very fair and expedient. Your follow up has been excellent. I have many publications in national and international journal and your process has been one of the best so far. Keep up the great work.

img

Douglas Miyazaki

We are grateful for this opportunity to provide a glowing recommendation to the Journal of Psychiatry and Psychotherapy. We found that the editorial team were very supportive, helpful, kept us abreast of timelines and over all very professional in nature. The peer review process was rigorous, efficient and constructive that really enhanced our article submission. The experience with this journal remains one of our best ever and we look forward to providing future submissions in the near future.

img

Dr Griffith

I am very pleased to serve as EBM of the journal, I hope many years of my experience in stem cells can help the journal from one way or another. As we know, stem cells hold great potential for regenerative medicine, which are mostly used to promote the repair response of diseased, dysfunctional or injured tissue using stem cells or their derivatives. I think Stem Cell Research and Therapeutics International is a great platform to publish and share the understanding towards the biology and translational or clinical application of stem cells.

img

Dr Tong Ming Liu

I would like to give my testimony in the support I have got by the peer review process and to support the editorial office where they were of asset to support young author like me to be encouraged to publish their work in your respected journal and globalize and share knowledge across the globe. I really give my great gratitude to your journal and the peer review including the editorial office.

img

Husain Taha Radhi

I am delighted to publish our manuscript entitled "A Perspective on Cocaine Induced Stroke - Its Mechanisms and Management" in the Journal of Neuroscience and Neurological Surgery. The peer review process, support from the editorial office, and quality of the journal are excellent. The manuscripts published are of high quality and of excellent scientific value. I recommend this journal very much to colleagues.

img

S Munshi

Dr.Tania Muñoz, My experience as researcher and author of a review article in The Journal Clinical Cardiology and Interventions has been very enriching and stimulating. The editorial team is excellent, performs its work with absolute responsibility and delivery. They are proactive, dynamic and receptive to all proposals. Supporting at all times the vast universe of authors who choose them as an option for publication. The team of review specialists, members of the editorial board, are brilliant professionals, with remarkable performance in medical research and scientific methodology. Together they form a frontline team that consolidates the JCCI as a magnificent option for the publication and review of high-level medical articles and broad collective interest. I am honored to be able to share my review article and open to receive all your comments.

img

Tania Munoz

“The peer review process of JPMHC is quick and effective. Authors are benefited by good and professional reviewers with huge experience in the field of psychology and mental health. The support from the editorial office is very professional. People to contact to are friendly and happy to help and assist any query authors might have. Quality of the Journal is scientific and publishes ground-breaking research on mental health that is useful for other professionals in the field”.

img

George Varvatsoulias

Dear editorial department: On behalf of our team, I hereby certify the reliability and superiority of the International Journal of Clinical Case Reports and Reviews in the peer review process, editorial support, and journal quality. Firstly, the peer review process of the International Journal of Clinical Case Reports and Reviews is rigorous, fair, transparent, fast, and of high quality. The editorial department invites experts from relevant fields as anonymous reviewers to review all submitted manuscripts. These experts have rich academic backgrounds and experience, and can accurately evaluate the academic quality, originality, and suitability of manuscripts. The editorial department is committed to ensuring the rigor of the peer review process, while also making every effort to ensure a fast review cycle to meet the needs of authors and the academic community. Secondly, the editorial team of the International Journal of Clinical Case Reports and Reviews is composed of a group of senior scholars and professionals with rich experience and professional knowledge in related fields. The editorial department is committed to assisting authors in improving their manuscripts, ensuring their academic accuracy, clarity, and completeness. Editors actively collaborate with authors, providing useful suggestions and feedback to promote the improvement and development of the manuscript. We believe that the support of the editorial department is one of the key factors in ensuring the quality of the journal. Finally, the International Journal of Clinical Case Reports and Reviews is renowned for its high- quality articles and strict academic standards. The editorial department is committed to publishing innovative and academically valuable research results to promote the development and progress of related fields. The International Journal of Clinical Case Reports and Reviews is reasonably priced and ensures excellent service and quality ratio, allowing authors to obtain high-level academic publishing opportunities in an affordable manner. I hereby solemnly declare that the International Journal of Clinical Case Reports and Reviews has a high level of credibility and superiority in terms of peer review process, editorial support, reasonable fees, and journal quality. Sincerely, Rui Tao.

img

Rui Tao

Clinical Cardiology and Cardiovascular Interventions I testity the covering of the peer review process, support from the editorial office, and quality of the journal.

img

Khurram Arshad